SF Patholab SRL
SF Patholab reported total assets of 164,640 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of SF Patholab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SF Patholab's annual accounts
| 2025 | |
|---|---|
| Net result | 112,807 € |
| Equity | 117,807 € |
| Cash | 162,564 € |
| EBITDA | 148,976 € |
| Total assets | 164,640 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
SF Patholab's financial analysis
- Solvency71.6%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SF Patholab
SF Patholab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1014.514.387
- VAT number
- BE1014514387
- Peppol
- Registered · 0208:1014514387 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2024
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
SF Patholab (SRL) has been based in Aalst since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 112,807 € and equity of 117,807 €; its revenue is not published. Its solvency stands at 71.6%, below the median of its sector (72.2%).
Companies similar to SF Patholab
Companies in the same business, of comparable size and area, outside its group.
- Julie Descy LAB&Advice Research and experimental development on natural sciences and engineering Seraing · balance sheet 164,570 €
- Lapisdomus Invest Market research and public opinion polling Seneffe · balance sheet 164,771 €
- Immo Drapiers Braine-le-Château · balance sheet 164,787 €
- GT-Immo Other information service activities Sint-Niklaas · balance sheet 164,827 €
- BEG Immo La Louvière · balance sheet 164,580 €
Frequently asked questions about SF Patholab
What is the revenue of SF Patholab?
SF Patholab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SF Patholab?
In Belgium, the VAT number is the company number prefixed with BE: BE1014514387 for SF Patholab, if the company is VAT-registered. Its company number (CBE) is 1014.514.387.
Where is the registered office of SF Patholab?
According to the CBE register, the registered office of SF Patholab is in 9300 Aalst.
What is the equity of SF Patholab?
At the close of the 2025 financial year, the equity of SF Patholab amounts to 117,807 €, a solvency of 71.6% of total assets.
Who manages SF Patholab?
The register lists 1 active mandates at SF Patholab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SF Patholab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →